AU2015301146B2 - Moving-horizon state-initializer for control applications - Google Patents

Moving-horizon state-initializer for control applications Download PDF

Info

Publication number
AU2015301146B2
AU2015301146B2 AU2015301146A AU2015301146A AU2015301146B2 AU 2015301146 B2 AU2015301146 B2 AU 2015301146B2 AU 2015301146 A AU2015301146 A AU 2015301146A AU 2015301146 A AU2015301146 A AU 2015301146A AU 2015301146 B2 AU2015301146 B2 AU 2015301146B2
Authority
AU
Australia
Prior art keywords
state
model
time
function
sensor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015301146A
Other languages
English (en)
Other versions
AU2015301146A1 (en
Inventor
Eyal Dassau
Francis J. Doyle Iii
Ravi L. Gondhalekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California, San Diego filed Critical University of California Berkeley
Publication of AU2015301146A1 publication Critical patent/AU2015301146A1/en
Application granted granted Critical
Publication of AU2015301146B2 publication Critical patent/AU2015301146B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Feedback Control In General (AREA)
AU2015301146A 2014-08-06 2015-08-05 Moving-horizon state-initializer for control applications Active AU2015301146B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034132P 2014-08-06 2014-08-06
US62/034,132 2014-08-06
PCT/US2015/043763 WO2016022650A1 (en) 2014-08-06 2015-08-05 Moving-horizon state-initializer for control applications

Publications (2)

Publication Number Publication Date
AU2015301146A1 AU2015301146A1 (en) 2017-03-16
AU2015301146B2 true AU2015301146B2 (en) 2020-06-25

Family

ID=55264479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015301146A Active AU2015301146B2 (en) 2014-08-06 2015-08-05 Moving-horizon state-initializer for control applications

Country Status (7)

Country Link
US (2) US9984773B2 (enExample)
EP (1) EP3177344B1 (enExample)
JP (1) JP6810991B2 (enExample)
CN (1) CN106714874B (enExample)
AU (1) AU2015301146B2 (enExample)
CA (1) CA2957432C (enExample)
WO (1) WO2016022650A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972296B2 (en) 2007-10-10 2011-07-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
WO2014172467A1 (en) 2013-04-16 2014-10-23 Smartloop Llc Discretionary insulin delivery systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
DE102015000845A1 (de) * 2015-01-27 2016-07-28 W.O.M. World Of Medicine Gmbh Verfahren und Vorrichtung zur Regelung der Temperatur des Gasstroms bei medizintechnischen Vorrichtungen
CA2977053C (en) 2015-02-18 2023-08-01 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
EP3374905A1 (en) 2016-01-13 2018-09-19 Bigfoot Biomedical, Inc. User interface for diabetes management system
EP4545005A3 (en) 2016-01-14 2025-07-02 Insulet Corporation Adjusting insulin delivery rates
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP4708310A3 (en) 2017-01-13 2026-05-06 Insulet Corporation Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708311A3 (en) 2017-01-13 2026-05-20 Insulet Corporation METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
US12653426B2 (en) 2017-07-13 2026-06-16 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
EP4765154A2 (en) 2017-08-02 2026-06-24 Diabeloop Closed-loop blood glucose control systems and methods
JP7133625B2 (ja) 2017-12-21 2022-09-08 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4354455B1 (en) 2019-12-06 2025-10-29 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
WO2021141941A1 (en) 2020-01-06 2021-07-15 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
WO2021158580A1 (en) 2020-02-03 2021-08-12 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11132352B1 (en) 2020-05-13 2021-09-28 International Business Machines Corporation Utilizing local IoT devices to reconcile data mismatches
JP7723008B2 (ja) 2020-05-27 2025-08-13 デックスコム・インコーポレーテッド 機械学習及び時系列グルコース測定値を使用したグルコース予測
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
EP4696344A3 (en) 2020-09-30 2026-04-15 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
CA3191704A1 (en) 2021-01-25 2022-07-28 Dexcom, Inc. Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
EP4285376A1 (en) 2021-01-29 2023-12-06 Insulet Corporation Techniques and devices that adapt basal profiles for drug delivery applications
US12636435B2 (en) 2021-02-26 2026-05-26 Insulet Corporation Techniques for optimizing usage of an automatic drug delivery system
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
WO2022192482A1 (en) 2021-03-10 2022-09-15 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
CN113223721B (zh) * 2021-03-23 2022-07-12 杭州电子科技大学 一种新型冠状病毒肺炎的预测控制模型
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
US12653949B2 (en) 2021-07-29 2026-06-16 Insulet Corporation Adaptation of medicament delivery in response to user stress load
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
WO2023150737A1 (en) 2022-02-07 2023-08-10 Insulet Corporation Techniques for determining medication correction factors in automatic medication delivery systems
US12653459B2 (en) 2022-02-23 2026-06-16 Massachusetts Institute Of Technology Systems, devices, and methods for blood pressure control
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
EP4511843A1 (en) 2022-04-21 2025-02-26 Insulet Corporation Insulin adaptation and safety monitoring for sick day management
KR20250129777A (ko) 2023-01-06 2025-08-29 인슐렛 코포레이션 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달
CN117170238B (zh) * 2023-09-15 2024-04-16 四川大学 基于协作分布式mpc的异构无人机集群搜索算法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100262117A1 (en) * 2007-11-02 2010-10-14 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US20120215087A1 (en) * 2009-11-02 2012-08-23 Universita Degli Studi Di Padova Method to recalibrate continuous glucose monitoring data on-line

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080119703A1 (en) * 2006-10-04 2008-05-22 Mark Brister Analyte sensor
US8364231B2 (en) * 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20080269714A1 (en) * 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US7717903B2 (en) * 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7695434B2 (en) * 2007-10-19 2010-04-13 Lifescan Scotland, Ltd. Medical device for predicting a user's future glycemic state
US8185217B2 (en) * 2008-01-31 2012-05-22 Fisher-Rosemount Systems, Inc. Robust adaptive model predictive controller with tuning to compensate for model mismatch
US20100057040A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US8734422B2 (en) * 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
EP2413781B1 (en) * 2009-03-31 2019-07-24 Abbott Diabetes Care Inc. Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model
US8597274B2 (en) * 2009-05-22 2013-12-03 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
WO2010135638A2 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Methods for reducing false hypoglycemia alarm occurrence
EP2433235A2 (en) * 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Safety features for integrated insulin delivery system
WO2011014851A1 (en) * 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US20110313680A1 (en) * 2010-06-22 2011-12-22 Doyle Iii Francis J Health Monitoring System
EP2628115B1 (en) * 2010-10-12 2015-06-03 The Regents of The University of California Insulin delivery device
CA2841086C (en) * 2011-09-28 2021-01-26 Abbott Diabetes Care Inc. Methods, devices and systems for analyte monitoring management
WO2013104006A2 (en) * 2012-01-08 2013-07-11 Sensor Platforms, Inc. System and method for calibrating sensors for different operating environments
US9907909B2 (en) * 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
EP2943150B1 (en) * 2013-01-14 2018-12-05 The Regents of The University of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US9486171B2 (en) * 2013-03-15 2016-11-08 Tandem Diabetes Care, Inc. Predictive calibration
CN103605878B (zh) * 2013-08-19 2016-03-30 浙江大学 一种基于数据建模和模型移植的通用血糖预测方法
CN103793594A (zh) * 2013-12-30 2014-05-14 上海交通大学医学院附属瑞金医院 一种构建肠道-胰岛调控轴相关功能评估模型的方法与应用
US10314547B2 (en) * 2014-04-09 2019-06-11 Halo Wearables LLC Calibration of a wearable medical device
US9949673B2 (en) * 2014-08-26 2018-04-24 MAXIM lNTEGRATED PRODUCTS, INC. System, method and apparatus with multiple reservoirs for in situ calibration of implantable sensors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100262117A1 (en) * 2007-11-02 2010-10-14 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US20120215087A1 (en) * 2009-11-02 2012-08-23 Universita Degli Studi Di Padova Method to recalibrate continuous glucose monitoring data on-line

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GONDHALEKAR, R. et al., "MPC design for rapid pump-attenuation and expedited hyperglycemia response to treat T1DM with an Artificial Pancreas", 2013 AMERICAN CONTROL CONFERENCE, 4 June 2014, pages 4224 - 4230. *

Also Published As

Publication number Publication date
WO2016022650A1 (en) 2016-02-11
JP2017523852A (ja) 2017-08-24
JP6810991B2 (ja) 2021-01-13
US20180277253A1 (en) 2018-09-27
CA2957432A1 (en) 2016-02-11
EP3177344A1 (en) 2017-06-14
AU2015301146A1 (en) 2017-03-16
US9984773B2 (en) 2018-05-29
CN106714874B (zh) 2019-10-08
CN106714874A (zh) 2017-05-24
US11189381B2 (en) 2021-11-30
EP3177344A4 (en) 2017-08-09
EP3177344B1 (en) 2023-06-28
US20170147781A1 (en) 2017-05-25
CA2957432C (en) 2017-07-25

Similar Documents

Publication Publication Date Title
US11189381B2 (en) Moving-horizon state-initializer for control applications
US12582772B2 (en) LQG artificial pancreas control system and related method
Bequette Algorithms for a closed-loop artificial pancreas: the case for model predictive control
Parker et al. The intravenous route to blood glucose control
Magni et al. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial
Cobelli et al. Artificial pancreas: past, present, future
Bondia et al. Insulin estimation and prediction: A review of the estimation and prediction of subcutaneous insulin pharmacokinetics in closed-loop glucose control
Parker et al. A model-based algorithm for blood glucose control in type I diabetic patients
Kovatchev et al. Control to range for diabetes: functionality and modular architecture
EP1881786B1 (en) Fully automated control system for type 1 diabetes
WO2016161254A1 (en) Methods and systems for analyzing glucose data measured from a person having diabetes
Pawłowski et al. Event-based MPC for propofol administration in anesthesia
KR20150097731A (ko) 인공 췌장의 혼성 목표 제어 및 범위 제어 모델 예측 제어를 위한 방법 및 시스템
Pagkalos et al. Bio-Inspired Glucose Control in Diabetes Based on an Analogue Implementation of a $\beta $-Cell Model
Patek et al. Linear quadratic gaussian-based closed-loop control of type 1 diabetes
Dalla Libera et al. In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing
Doyle et al. I. Glucose control strategies for treating type 1 diabetes mellitus
Gondhalekar et al. State Estimation with Sensor Recalibrations and Asynchronous Measurements for MPC of an Artificial Pancreas to Treat T1DM
Bequette Challenges and progress in the development of a closed-loop artificial pancreas
Chandrasekhar et al. An android phone based artificial pancreas system for type-1 diabetic patients
Incremona et al. Artificial pancreas: from control-to-range to control-to-target
Ata et al. Model based control of artificial pancreas under meal disturbances
Pepe et al. Local sampled-data control of the glucose-insulin system
Khodadadi et al. Improved sliding mode control for glucose regulation of type 1 diabetics patients considering delayed nonlinear model
Ludwig et al. T1DM subject as a time-delay system: Modeling and adaptive control

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)